Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21200077 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Staccato® Loxapine Treatment of Schizophrenic Patients With Agitation
Condition: Schizophrenic Patients With Acute Agitation
Interventions: Drug: loxapine;   Drug: placebo

Indicates status has not been verified in more than two years